FDA Panel: No Answers to MoM Hip Dilemma (MedPageToday)
Two days of public hearings yielded little in the way of solid information for an FDA advisory panel to use in promulgating new policy recommendations for use of metal-on-metal (MoM) hip implants.
The FDA's Orthopaedic Surgery and Rehabilitation Devices panel, meeting Wednesday and Thursday, had been tasked with providing recommendations on how to manage patients who have received such devices and whether they should be used at all in new patients.
Where Are the Data?
Toward the end of the 2-day meeting, Scott Evans, PhD, a Harvard Univer...
